Disciplines:
  • Nursing
  • Advanced Practice Nursing
  • Psychiatric Technicians
Hours:

3 Contact Hours

(1 pharm hour)

Author(s): Voncella McCleary-Jones, PhD, RN, BC
Peer Reviewer(s): Carolyn H. McGrory, MS, RN
Item#: N1606
Content:
1 Course Book (36 pages)

Management of Systemic Lupus Erythematosus, Updated 1st Edition



Reg. Price $19.95
Sale $14.95
Item # N1606
When available, the Online Course format is included with the hard copy, eBook, or audio book formats!

Expiration Date: December 31, 2017

Systemic lupus erythematosus (SLE) is an inflammatory disease of autoimmune origin that affects many parts of the body, including the skin, joints, serous membranes, and the renal, hematologic, and neurologic systems (Lewis, Heitkemper, Dirksen, O’Brien, & Bucher, 2007). The immune system of a person with SLE identifies normal body tissues as foreign and causes the body’s defenses to attack its own tissues. A combination of genetic, hormonal, environmental, and immunologic factors interact in this disorder.

SLE is a chronic disease marked by periods of exacerbations and remissions. Some form of Lupus affects about 1.5 million Americans, and at least 5 million people worldwide, with 90% being women (Lupus Foundation of America, 2014). Most cases of SLE occur in women during childbearing years. African Americans, Asian Americans, Hispanics, and Native Americans are more likely than Caucasians to develop the disease (Lemone & Burke, 2008; Lewis et al., 2007).

Given the aforementioned incidence of SLE, nurses working in acute-care and in-home healthcare settings are likely to encounter individuals affected by the disease. SLE can manifest in various ways and affect several body systems. Without proper disease management, this can have a negative impact on healthcare outcomes. It is exceedingly important that healthcare providers be aware of appropriate measures for SLE management to facilitate effective care and assist those affected by SLE to maintain optimum health and experience reduced complications related to the disease’s effects.

The purpose of this course is to provide nurses and other healthcare providers with information on the etiology, pathophysiology, clinical manifestations, diagnostic studies, nursing diagnoses and interventions, and collaborative care used during management of SLE. A case study is provided to allow participants to apply knowledge acquired from this course to the care of a client who has SLE.

Orthopaedic Nurses - ONCB has approved this course for 3 contact hours in Category A toward recertification.

Course Objectives

  • Discuss the incidence of systemic lupus erythematosus (SLE) and the demographics of individuals who are most likely to be affected by SLE.
  • Explain the etiology and pathophysiology of SLE.
  • Identify the common, presenting signs and symptoms of SLE.
  • Recognize diagnostic tests commonly used during diagnosis and management of SLE.
  • Select appropriate nursing diagnoses and interventions for a client with SLE.
  • Discuss collaborative care modalities used during management of SLE.
Voncella McCleary-Jones, Ph.D, RN, BC, has been a registered nurse for 23 years with clinical experience in medical-surgical nursing, intensive care, critical care, and post-anesthesia care. She has been a nurse educator for 13 years, and has taught at the associate degree, baccalaureate degree, and master’s degree levels. Dr. McCleary-Jones holds certifications in basic cardiac life support, advanced cardiac life support, and in medical-surgical nursing from the American Nurses Credentialing Center. She has presented in national and international forums, and is the author of several publications appearing in national refereed journals on the topics of health promotion, the Americans with Disabilities Act, disability support services, learning disabilities, and nursing students’ issues. Dr. McCleary-Jones is currently an assistant professor in the University of Oklahoma College of Nursing in Oklahoma City, Oklahoma.
Carolyn H. McGrory, MS, RN, cared for and studied patients with systemic lupus erythematosus (SLE) at the Lupus Study Center at Hahnemann University and Thomas Jefferson University in Philadelphia, PA, for 15 years. She serves on the Medical Advisory Board and the Patient Services Committee of the Philadelphia Tri-State Chapter of the Lupus Foundation of America. Ms. McGrory is a member of the American College of Rheumatology and has presented work at national meetings. She has been the recipient of over $300,000 in grant support from the Commonwealth of Pennsylvania, studying various aspects of SLE, including fatigue, spousal relationships, and efficacy of support groups. Ms. McGrory has co-authored 40 scholarly articles, including “Pregnancy Outcomes in Female Renal Recipients: A Comparison of SLE With Other Diagnoses,” in the American Journal of Transplantation.
  • Contact hours will be awarded for up to one (1) year from the date the course is ordered.
  • You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
  • Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools’ policy not to accept commercial support.
  • All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.